Cytex Therapeutics Inc entered the industry of Research and Development Laboratories in 2006 and has grown to employ 1 to 4 people, generating an annual revenue of $0 to $49.999. The NAICS classifies this business under the code 541712, which describes it as a Research and Development Laboratories. For further clarification, the SIC classifies this business under the code 8731 and described it as a Research and Development Laboratories. The business provides service to the B2B market.
To acquire more information, please contact Farshid Guilak by calling (919) 912-9837 during business hours. You can also write to the business’ Single Location at 2608 Erwin Road # 19a, Durham, North Carolina NC 27705. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Cytex Therapeutics Inc |
Representative: | Farshid Guilak |
Place of Business: | 2608 Erwin Road # 19a, Durham, NC 27705 |
Contact Number: | (919) 912-9837 |
Type of Service: | Research and Development Laboratories |
SIC Number: | 8731 |
NAICS Number: | 541712 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2006 |
Income/Year: | $0 to $49.999 |
Laborers: | 1 to 4 |
Share This Company: |
Cytex Therapeutics Inc is a company operating from Durham, North Carolina providing professional Research and Development Laboratories and relevant B2B variables. It was founded in 2006 and registered with the SIC code 8731 as Research and Development Laboratories, and with the NAICS code 541712 as Research and Development Laboratories.
With a current employee count of 1 to 4, Cytex Therapeutics Inc has gone to report making $0 to $49.999 per annum on its journey towards growth. This company invites you to contact its representative Farshid Guilak at (919) 912-9837 for related queries, or to locate its Single Location using the coordinates 36.00885,-78.944306.
The Single Location can also be found at the street address 2608 Erwin Road # 19a in Durham, North Carolina 27705 and can be engaged online through the company website at , the company Twitter , and Facebook page .